5Lee AY,LevineMN.Venous thromboembolismand cancer:Risks and outcomes[J].Circulation,2003,107:117
6Stein P,Beemath A,Meyers F,et al.Incidence of venous thromboembolism in patientshospitalized with cancer[J].AmJMed.2006,119:60
7Khorana A,Francis C,Culakova E,et al.Frequency,risk factors,and trends for venousthromboembolism among hospitalized cancer patients[J].Cancer.2007,110:2339
8Geerts W,Pineo G,Heir J,et al.Prevention of venous thromboembolism:The seventh ACCPconference on antithrombotic and thronbolytic therapy[J].Chest,2004,126:338S
9Bergqvist D,Agnelli G,Cohen AT,et al.Duration of prophylaxis against venousthromboembolism with enoxaparin after surgery for accner[J].N Engl J Med,2002,346:975
10Haas SK,Kakkar AK,Kemkes-Mahes B,et al.Prevention of venous thromboembolism withlowmolecularweight heparin in patients with metastatic breast or lung cancer:Results ofthe TOPIC studies[J].J Thromb Haemost.2005,3 (suppll):AbstOR059
